Jackie Wright Bonilla, Senior Counsel with Foley will be speaking at the 2nd Patent Strategies for the Pharma, Biotech and Medical Device Industries Conference in Philadelphia, July 15-16, 2008.
Ms. Bonilla’s panel will take place on Tuesday, July 15th and will cover the following topics:
- Examining the existing 505(b)2 pathway for approval of follow-on biologics
- Debating the future of follow-on biologics legislation in 2008 and beyond
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.